Suchergebnisse - "Ishikawa, Tomofumi"

PubPharm (30)

1

Prescribing in pregnant women with inflammatory bowel disease and its relationship to congenital malformations in Japan

enthalten in: Journal of gastroenterology and hepatology | 2024

von Takahashi, S. | Kakuta, Y. | Obara, T. | +9

2

Real-world prevalence, time of diagnosis, and co-occurrence patterns of birth defects in live-born infants, 2014-2020 : A health administrative database study in Japan

enthalten in: Birth defects research | 2023

von Ishikawa, T. | Kawame, H. | Mano, N. | +1

3

Risk of major congenital malformations associated with first-trimester antihypertensives, including amlodipine and methyldopa : A large claims database study 2010-2019

enthalten in: Pregnancy hypertension | 2023

von Ishikawa, T. | Nishigori, H. | Akazawa, M. | +12

4

No association between major congenital malformations and exposure to Kampo medicines containing rhubarb rhizome : A Japanese database study

enthalten in: Frontiers in pharmacology | 2023

von Suzuki, S. | Obara, T. | Ishikawa, T. | +8

5

Development and validation of claims-based algorithms to identify pregnancy based on data from a university hospital in Japan

enthalten in: Current medical research and opinion | 2022

von Tajima, K. | Ishikawa, T. | Noda, A. | +9

6

Validity of Administrative Data for Identifying Birth-Related Outcomes with the End Date of Pregnancy in a Japanese University Hospital

enthalten in: International journal of environmental research and public health | 2022

von Tajima, K. | Ishikawa, T. | Matsuzaki, F. | +9

7

Risk of major congenital malformations associated with first-trimester exposure to propulsives : A health administrative database study in Japan

enthalten in: Pharmacoepidemiology and drug safety | 2022

von Ishikawa, T. | Obara, T. | Akazawa, M. | +9

8

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer : Updated Results of a Randomized, Double-Blind Study

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2022

von Li, R. | Tokunaga, E. | Adamchuk, H. | +9

9

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study

enthalten in: BioDrugs | 2022

von Li, R. | Tokunaga, E. | Adamchuk, H. | +9

10

Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind Study

enthalten in: BioDrugs | 2022

von Li, R. | Tokunaga, E. | Adamchuk, H. | +9